TAMER WASSEF: Open Payments
NPI 1255654752 · JERSEY CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 24 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $2,281 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $163 |
| ABBVIE INC. | 13 | $141 |
| Alkermes, Inc. | 3 | $57 |
| Bausch Health US, LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Braeburn Inc. | 1 | $16 |
Products named: COBENFY, VRAYLAR, VIVITROL, WELLBUTRIN, ARISTADA, TRINTELLIX, BRIXADI.
Industry payments across NJ — which companies pay providers there.
